Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection

1

Review clinical trials related to Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

The objective of this study is to determine if early high volume intravenous fluid administration (hyperhydration) may be effective in mitigating or preventing complications of shiga toxin-producing E. coli (STEC) infection in children and adolescents when compared with traditional approaches (conservative fluid management).

Participants needed: 1,040
Trial details
Age: 9-21Biological sex: AllType: InterventionalSponsor: University of CalgaryUpdated: May 18, 2026Locations: 26
Eligibility criteria

Aged 9.0 months to <21 years at the time of informed consent. [+8]

Hematocrit <30% AND [+11]